First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
Laboratory is dedicated solely to malignant pleural mesothelioma (MPM); pleural mesothelioma is an asbestos-related cancer of the chest lining (pleura)
LOS ANGELES, Dec. 22, 2011 /PRNewswire/ -- Thanks to continued generous support from mesothelioma victims, their families, friends, and advocates, the Pacific Meso Center (PMC) announces the opening of its new state-of-the-art mesothelioma research laboratory dedicated solely to the discovery of new treatments for malignant pleural mesothelioma (MPM), a cancer of the chest lining caused by asbestos exposure.
Pacific Meso Center (PMC) is a division of the Pacific Heart, Lung & Blood Institute (PHLBI), a 501(c)(3) non-profit medical research organization established in 2002, and is focused on both the treatment and prevention of MPM.
As the first of its kind in the world, the research lab was established to lead a focused and collaborative mesothelioma research effort that is independent of the limitations often imposed by academic as well as private medical institutions. The lab will focus not only on the development of novel treatments for mesothelioma but also on its prevention. More...
Two Top Law Firms Back Mesothelioma Research at the Pacific Meso Center
LOS ANGELES, Sept. 6, 2011 /PRNewswire/ -- The Pacific Meso Center (PMC) is pleased to announce and recognize generous donations from the law offices of Roger G. Worthington PC in San Pedro, California and The Asbestos Legal Center in San Francisco, California.
PMC is part of The Pacific Heart, Lung & Blood Institute (PHLBI), a 501(c)(3) non-profit medical research institute, and serves as PHLBI's comprehensive research and support center for malignant pleural mesothelioma (MPM), an asbestos-induced cancer. Currently, MPM has no known cure and very few effective treatment options. PMC's programs are focused on supportive patient care and the discovery and development of novel treatments for MPM. More...
Amgen's Breakaway from Cancer April 30th Event Raises $50,000
LOS ANGELES, May 11, 2011 -- /PRNewswire/ -- The Dana Point Community Cycling Foundation, in conjunction with Amgen's Breakaway from Cancer initiative, hosted a successful fundraiser at the Dana Point Yacht Club on Saturday, April 30th. Over 350 guests attended an evening of food, wine, beer, entertainment and a fabulous silent auction with many prestigious items up for bid. The Pacific Meso Center (PMC) at PHLBI will be one of the beneficiaries from this event, whose mission it is to raise funds for better treatments and research that will eventually lead to a cure for mesothelioma, a deadly cancer caused by exposure to asbestos. Other local charities will also benefit from this initiative.
As part of the weekend festivities, the Saturday Breakaway from Cancer Night was also a kick-off for the nationally recognized Sunday May 1st, Breakaway from Cancer 5th Annual Dana Point Grand Prix. The event, hosted by the City of Dana Point and organized by the DPCCF, drew a record crowd of thousands of enthusiastic fans to watch international and domestic cycling pros in the main event broadcast live on YouTube. Spectators also came to support, cheer and participate with hundreds of survivors, caregivers and family members who gathered to walk on the most beautiful bicycle race course in the USA immediately prior to the Pro main event, as part of the "Breakaway from Cancer Walk" to celebrate life. More...
Pacific Meso Center to Help Sponsor One-Day Seminar on Lung-Sparing Therapies for Pleural Mesothelioma
LOS ANGELES, Feb. 15, 2011 /PRNewswire/ -- The Pacific Meso Center (PMC) at The Pacific Heart, Lung, & Blood Institute is pleased to announce that it has agreed to help sponsor a UCLA Seminar on Lung-Sparing Therapies for Malignant Pleural Mesothelioma, an asbestos-related cancer involving the lining of the chest (pleura). This will be the first scientific seminar of its kind featuring cancer treatments that preserve the victims' lungs. This unique one-day seminar will take place on Saturday, May 21st at the Sheraton Delfina in Santa Monica, from 8:00 a.m. to 5:00 p.m.
The course will be led by Dr. Robert B. Cameron, Director of the Mesothelioma Research Program at the David Geffen School of Medicine at UCLA, Chief of Thoracic Surgery at the West Los Angeles Veterans' Administration Medical Center, and a long-time advocate for lung-sparing surgery. More...
Medical Research Institute Focusing on Treatment of Mesothelioma Launches New Patient Resource Website
LOS ANGELES, Aug. 24 /PRNewswire/ -- The Pacific Heart, Lung & Blood Institute ("PHLBI"), a non-profit medical research institute focusing on the treatment and prevention of malignant pleural mesothelioma, is proud to announce the launch of its new website: http://www.phlbi.org.
With substantial contributions from PHLBI's Scientific Advisor, renowned cardiothoracic surgeon and surgical oncologist Dr. Robert Cameron, phlbi.org is a unique resource where patients, caregivers and providers can obtain up-to-date information about pleural mesothelioma and Dr. Cameron's innovative approach to treating the disease. More...
